Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,870 | -1,460 | -1,010 | -500 | -2,440 |
| Depreciation Amortization | 20 | 10 | 10 | 4 | 10 |
| Other Working Capital | 210 | 90 | 5 | 5 | -10 |
| Other Operating Activity | 160 | 170 | 115 | 71 | 580 |
| Operating Cash Flow | $-1,480 | $-1,190 | $-880 | $-420 | $-1,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -20 | -2 | -2 | -10 |
| Other Investing Activity | -70 | -50 | -48 | 0 | 0 |
| Investing Cash Flow | $-90 | $-70 | $-50 | $-2 | $-10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 30 | 30 | 0 | 0 | 2,480 |
| Financing Cash Flow | $30 | $30 | $0 | $0 | $2,480 |
| Beginning Cash Position | 1,550 | 1,550 | 1,550 | 1,550 | 940 |
| End Cash Position | 10 | 320 | 620 | 1,120 | 1,550 |
| Net Cash Flow | $-1,540 | $-1,230 | $-930 | $-420 | $600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,480 | -1,190 | -880 | -420 | -1,860 |
| Free Cash Flow | -1,480 | -1,190 | -880 | -420 | -1,860 |